Platelet WDR1 suppresses platelet activity and is associated with cardiovascular disease.
Platelet activity plays a major role in hemostasis with increased platelet activity likely contributing to the pathogenesis of atherothrombosis. We sought to identify associations between platelet activity variability and platelet-related genes in healthy controls. Transcriptional profiling of platelets revealed that WD-40 repeat domain 1 (WDR1), an enhancer of actin-depolymerizing factor activity, is downregulated in platelet messenger RNA (mRNA) from subjects with a hyperreactive platelet phenotype. We used the human megakaryoblastic cell line MEG-01 as an in vitro model for human megakaryocytes and platelets. Stimulation of MEG-01 with thrombin reduced levels of WDR1 transcripts and protein. WDR1 knockdown (KD) in MEG-01 cells increased adhesion and spreading in both the basal and activated states, increased F-actin content, and increased the basal intracellular calcium concentration. Platelet-like particles (PLPs) produced by WDR1 KD cells were fewer in number but larger than PLPs produced from unmodified MEG-01 cells, and had significantly increased adhesion in the basal state and upon thrombin activation. In contrast, WDR1 overexpression reversed the WDR1 KD phenotype of megakaryocytes and PLPs. To translate the clinical significance of these findings, WDR1 expression was measured in platelet RNA from subjects with established cardiovascular disease (n = 27) and age- and sex-matched controls (n = 10). The WDR1 mRNA and protein level was significantly lower in subjects with cardiovascular disease. These data suggest that WDR1 plays an important role in suppressing platelet activity, where it alters the actin cytoskeleton dynamics, and downregulation of WDR1 may contribute to the platelet-mediated pathogenesis of cardiovascular disease.
Divisions of Cardiology and Hematology, Department of Medicine, New York University School of Medicine, New York, NY.
Emilie
E
Montenont
Divisions of Cardiology and Hematology, Department of Medicine, New York University School of Medicine, New York, NY.
Christina
C
Echagarruga
Divisions of Cardiology and Hematology, Department of Medicine, New York University School of Medicine, New York, NY.
Nicole
N
Allen
Section of Comparative Medicine and Department of Pathology, Yale University School of Medicine, New Haven, CT; and.
Elisa
E
Araldi
Section of Comparative Medicine and Department of Pathology, Yale University School of Medicine, New Haven, CT; and.
Yajaira
Y
Suarez
Divisions of Cardiology and Hematology, Department of Medicine, New York University School of Medicine, New York, NY.|Division of Vascular Surgery, Department of Surgery, New York University School of Medicine, New York, NY.
Jeffrey S
JS
Berger
D000328:Adult; D050197:Atherosclerosis / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D001792:Blood Platelets / Q000378:metabolism* / Q000473:pathology; D002460:Cell Line; D003599:Cytoskeleton / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D005260:Female; D005786:Gene Expression Regulation; D006801:Humans; D008297:Male; D008533:Megakaryocytes / Q000378:metabolism / Q000473:pathology; D008840:Microfilament Proteins / Q000096:biosynthesis* / Q000235:genetics; D010973:Platelet Adhesiveness
D008840:Microfilament Proteins; C118067:WDR1 protein, human